首页> 美国卫生研究院文献>Biochemical Journal >1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide.
【2h】

1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide.

机译:1-甲基-4-苯基吡啶鎓(MPP +)诱导的细胞凋亡和线粒体氧化剂的产生:转铁蛋白受体依赖性铁和过氧化氢的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1-Methyl-4-phenylpyridinium (MPP(+)) is a neurotoxin used in cellular models of Parkinson's Disease. Although intracellular iron plays a crucial role in MPP(+)-induced apoptosis, the molecular signalling mechanisms linking iron, reactive oxygen species (ROS) and apoptosis are still unknown. We investigated these aspects using cerebellar granule neurons (CGNs) and human SH-SY5Y neuroblastoma cells. MPP(+) enhanced caspase 3 activity after 24 h with significant increases as early as 12 h after treatment of cells. Pre-treatment of CGNs and neuroblastoma cells with the metalloporphyrin antioxidant enzyme mimic, Fe(III)tetrakis(4-benzoic acid)porphyrin (FeTBAP), completely prevented the MPP(+)-induced caspase 3 activity as did overexpression of glutathione peroxidase (GPx1) and pre-treatment with a lipophilic, cell-permeable iron chelator [N, N '-bis-(2-hydroxybenzyl)ethylenediamine-N, N '-diacetic acid, HBED]. MPP(+) treatment increased the number of TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labelling)-positive cells which was completely blocked by pre-treatment with FeTBAP. MPP(+) treatment significantly decreased the aconitase and mitochondrial complex I activities; pre-treatment with FeTBAP, HBED and GPx1 overexpression reversed this effect. MPP(+) treatment increased the intracellular oxidative stress by 2-3-fold, as determined by oxidation of dichlorodihydrofluorescein and dihydroethidium (hydroethidine). These effects were reversed by pre-treatment of cells with FeTBAP and HBED and by GPx1 overexpression. MPP(+)-treatment enhanced the cell-surface transferrin receptor (TfR) expression, suggesting a role for TfR-induced iron uptake in MPP(+) toxicity. Treatment of cells with anti-TfR antibody (IgA class) inhibited MPP(+)-induced caspase activation. Inhibition of nitric oxide synthase activity did not affect caspase 3 activity, apoptotic cell death or ROS generation by MPP(+). Overall, these results suggest that MPP(+)-induced cell death in CGNs and neuroblastoma cells proceeds via apoptosis and involves mitochondrial release of ROS and TfR-dependent iron.
机译:1-甲基-4-苯基吡啶鎓(MPP(+))是帕金森氏病细胞模型中使用的一种神经毒素。虽然细胞内铁在MPP(+)诱导的细胞凋亡中起着关键作用,但连接铁,活性氧(ROS)和细胞凋亡的分子信号传导机制仍然未知。我们使用小脑颗粒神经元(CGNs)和人SH-SY5Y神经母细胞瘤细胞研究了这些方面。 MPP(+)增强了24小时后的caspase 3活性,最早在细胞处理后12 h显着增加。用金属卟啉抗氧化酶模拟物Fe(III)四(4-苯甲酸)卟啉(FeTBAP)预处理CGNs和神经母细胞瘤细胞,完全抑制了MPP(+)诱导的caspase 3活性,就像谷胱甘肽过氧化物酶的过表达一样( GPx1)并用亲脂性,可渗透细胞的铁螯合剂进行预处理[N,N'-双-(2-羟基苄基)乙二胺-N,N'-二乙酸,HBED]。 MPP(+)处理增加了TUNEL(末端脱氧核苷酸转移酶介导的dUTP缺口末端标记)阳性细胞的数量,这些细胞被FeTBAP预处理完全阻断了。 MPP(+)处理显着降低乌头酸酶和线粒体复合体I的活性;用FeTBAP,HBED和GPx1过度治疗可以逆转这种作用。 MPP(+)处理使细胞内氧化应激增加了2-3-倍,这是由二氯二氢荧光素和二氢乙啶(氢乙啶)的氧化确定的。通过用FeTBAP和HBED预处理细胞以及GPx1过表达可以逆转这些作用。 MPP(+)-处理增强了细胞表面转铁蛋白受体(TfR)的表达,表明TfR诱导的MPP(+)毒性中铁吸收的作用。抗TfR抗体(IgA类)对细胞的治疗抑制了MPP(+)诱导的caspase活化。一氧化氮合酶活性的抑制作用不影响caspase 3活性,凋亡细胞死亡或MPP(+)产生的ROS。总体而言,这些结果表明,MPP(+)诱导的CGNs和神经母细胞瘤细胞死亡通过细胞凋亡进行,并涉及线粒体释放ROS和TfR依赖性铁。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号